Data / Form D filings / Kayak Therapeutics, Inc.
Kayak Therapeutics, Inc.: Form D filings
Kayak Therapeutics, Inc., a biotechnology company in Austin, TX, filed 3 Form D notices with the SEC between 2025 and 2026. The latest, on August 21, 2026, reports $25 million sold of a $30 million offering to 137 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3317 BOWMAN AVENUE, Austin, TX, 78703
- Phone
- (917) 892-9996
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2088831
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Amendment | $30,000,000 | $24,981,000 | $5,019,000 | 137 | May 12, 2026 | sec.gov |
| May 27, 2026 | New notice | $25,000,000 | $11,940,000 | $13,060,000 | 55 | May 12, 2026 | sec.gov |
| Sep 29, 2025 | New notice | $10,000,000 | $6,630,000 | $3,370,000 | 42 | Sep 11, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josiah Hornblower | Executive Officer, Director | |
| Tyler Brous | Director | |
| Conor Richardson | Executive Officer | |
| Taylor Schreiber | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
- BioGene Therapeutics Inc. $3 million · Aug 7, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kayak Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.